# Doxazosin

NDC: 51655-130
Generic name: Doxazosin Mesylate
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230227
Marketing ended: 20270831
FDA application: ANDA209013

## Active ingredients

- DOXAZOSIN MESYLATE: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-130"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-130
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6c9856e-9154-f349-e053-6294a90a9f2c